The current COVID-19 outbreak has created tremendous awareness of the importance of thorough disinfection. Given the extraordinary challenges facing healthcare systems and hospitals today, it is critical that the healthcare industry transform its disinfection and cleaning protocols to focus on deadly pathogen elimination to ensure the greatest safety for staff, patients and the public.
Even before COVID-19, hospital-borne pathogens were infecting hospital patients at an unacceptably high rate and in too many cases causing severe illness and even death. The Centers for Disease Control and Prevention estimates that almost 100,000 people die annually in the United States from healthcare-associated infections.
Nevoa® Inc.— a local company based in Tempe, Arizona, with extensive experience in technology, healthcare and product development — has launched one of the most technologically advanced disinfecting systems currently on the market, called Nimbus™. Nimbus is a whole-room disinfecting robot that uses a proprietary fogging technique for disinfecting hospital patient rooms as well as other enclosed spaces.
The patented Nimbus robot, when used in conjunction with Nevoa Microburst Solution, not only kills SARS CoV-2 (the coronavirus that causes COVID-19) but also kills other deadly pathogens, including Staph, MRSA, C. diff. and Influenza A. Microburst is proven to be greater than 99.99 percent effective at disinfection, and is an EPA-registered, hospital-grade disinfectant whose active ingredient is Hypochlorous acid (HOCl).
The no-touch, automated robot Nimbus is placed inside a hospital patient room and all vents and doors are temporarily sealed. Nimbus is controlled by a smart tablet just outside the room and guides the user to initiate the disinfection process. Microburst disinfecting solution is atomized, or fogged, by Nimbus, and the fine mist contacts all surfaces in the room for whole-room disinfection. Nimbus then uses its patented filtration and dehumidification Rapid Room™ Technology to eliminate the disinfecting solution from the air and surfaces, while logging the process data for quality control. This allows for immediate room re-entry with no waiting required. It takes only about 30 minutes to disinfect an entire room, which lets the next hospital patient to be admitted, quickly and safely, to a clean, disinfected room.
The Nimbus + Microburst disinfection cycle is one of the fastest and most effective technologies currently available to healthcare facilities. Unlike ultraviolet (UV) disinfecting systems, Nimbus + Microburst’s whole-room fogging eliminates shadowing effects where pathogens can hide, and leaves no unpleasant odors behind.
Led by inspired, passionate creators who approach problems from a unique perspective, Nevoa has invented solutions that are currently being used in hospitals around the country to help eliminate deadly pathogens commonly found in patient rooms.
Nevoa’s goal is to invent disinfection products that kill pathogens that cause healthcare-associated infections and, ultimately, to save the lives of people in environments where germs and pathogens are known to thrive. Nevoa is transforming the healthcare industry’s decades-old disinfection and cleaning protocols to highly effective, automated protocols that disinfect better.
This technology is already changing the way hospitals approach whole-room disinfection.
Ernest Cunningham is president of Nevoa Inc., a company committed to disinfection technology designed to kill deadly pathogens commonly found in healthcare settings.
Photos courtesy of Nevoa Inc.
